Botulinum toxin in the treatment of tics

被引:103
|
作者
Kwak, CH
Hanna, PH
Jankovic, J
机构
[1] Baylor Coll Med, Parkinsons Dis Ctr, Dept Neurol, Houston, TX 77030 USA
[2] Baylor Coll Med, Movement Disorders Clin, Dept Neurol, Houston, TX 77030 USA
[3] JFK Med Ctr, New Jersey Neurosci Inst, Edison, NJ USA
关键词
D O I
10.1001/archneur.57.8.1190
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the safety and efficacy of botulinum toxin A (BTX) injections in the treatment of ties in patients with Tourette syndrome (TS). Background: BTX is an effective treatment for an increasing number of conditions characterized by abnormal muscle contractions. BTX may improve not only the motor component of ties, but also premonitory sensations that precede ties. Methods: Thirty-five patients (30 male, 5 female) were treated with BTS in the sites of their most problematic ties. Response to BTX was based on a 0 to 4 clinical rating scale (0, no improvement, to 4, marked improvement in both severity and function). Questionnaires were administered to evaluate patients' impressions of overall efficacy and degree of benefit with premonitory sensations. Results: Mean duration of ties prior to initial injection was 15.3 years (range, 1-62 years) and mean duration of follow-up was 21.2 months (range, 1.5-84 months). The mean peak effect response in 35 patients treated in 115 sessions was 2.8 (range, 0-4); the mean duration of benefit was 14.4 weeks (maximum, 45 weeks), and the mean latency to onset of benefit was 3.8 days (maximum, 10 days). Twenty-one (84%) of 25 patients with premonitory sensations derived marked relief of these symptoms (mean benefit, 70.6%). Total mean dose was 502.1 U (range, 15-3550 U); mean number of visits, 3.3 (range, 1-16); and mean dose per visit, 119.9 U (range, 15-273 U). Sites of injections were as follows: cervical or upper thoracic area (17), upper face (14), lower face (7), vocal cords (dr), upper back and/or shoulder (3), scalp (1), forearm (1), leg (1) and rectus abdominis (1). Complications included neck weakness (4), dysphagia (2), ptosis (2), nausea (1), hypophonia (1), fatigue (1), and generalized weakness (1), which were all mild and transient. Conclusions: Botulinum toxin A injections are an effective and well-tolerated treatment of ties. In addition to improving the motor component of ties, BTX also provides relief of premonitory sensations.
引用
收藏
页码:1190 / 1193
页数:4
相关论文
共 50 条
  • [1] Botulinum Toxin for the Treatment of Tremor and Tics
    Lotia, Mitesh
    Jankovic, Joseph
    SEMINARS IN NEUROLOGY, 2016, 36 (01) : 54 - 63
  • [2] BOTULINUM TOXIN IN THE TREATMENT OF DYSTONIC TICS
    JANKOVIC, J
    MOVEMENT DISORDERS, 1994, 9 (03) : 347 - 349
  • [3] Ear wiggling tics: treatment with botulinum toxin injection
    Srirompotong, Supaporn
    Saeseow, Patchareeporn
    Kharmwan, Samerduan
    Srirompotong, Somchai
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2007, 264 (04) : 385 - 387
  • [4] Ear wiggling tics: treatment with botulinum toxin injection
    Supaporn Srirompotong
    Patchareeporn Saeseow
    Samerduan Kharmwan
    Somchai Srirompotong
    European Archives of Oto-Rhino-Laryngology, 2007, 264 : 385 - 387
  • [5] BOTULINUM TOXIN IN THE TREATMENT OF TICS ASSOCIATED WITH TOURETTES-SYNDROME
    JANKOVIC, J
    NEUROLOGY, 1993, 43 (04) : A310 - A310
  • [6] Botulinum Toxin for the Treatment of Motor and Phonic Tics: A Case Report
    Kohli, Nikita
    Blitzer, Andrew
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2020, 129 (06): : 625 - 627
  • [7] Botulinum toxin for refractory vocal tics
    Salloway, S
    Stewart, CF
    Israeli, L
    Morales, X
    Rasmussen, S
    Blitzer, A
    Brin, MF
    MOVEMENT DISORDERS, 1996, 11 (06) : 746 - 748
  • [8] Botulinum toxin in the management of laryngeal tics
    Vincent, Daniel A., Jr.
    JOURNAL OF VOICE, 2008, 22 (02) : 251 - 256
  • [9] The treatment of vocal tics in Tourette patients using botulinum toxin type A
    Porta, M
    Camerlingo, M
    Maggioni, G
    Perretti, A
    Dell'Anna, E
    MOVEMENT DISORDERS, 2002, 17 : S341 - S341
  • [10] Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A
    M. Porta
    G. Maggioni
    F. Ottaviani
    A. Schindler
    Neurological Sciences, 2004, 24 : 420 - 423